Telomere length variation: A potential new telomere biomarker for lung cancer risk

Lung Cancer

Volumn 88, Issue 3, 2015, Pages 297-303

  Sun, Bing ^a   Wang, Ying ^a   Kota, Krishna ^a   Shi, Yaru ^a   Motlak, Salaam ^a   Makambi, Kepher ^a,b   Loffredo, Christopher A ^a,b   Shields, Peter G ^c   Yang, Qin ^d   Harris, Curtis C ^e   Zheng, Yun Ling ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Blood based biomarker; Lung cancer; Risk prediction; Telomere dysfunction; Telomere length; Telomere length variation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; TELOMERE HOMEOSTASIS; TELOMERE LENGTH VARIATION; VERY ELDERLY; GENETICS; HUMAN CHROMOSOME; LUNG TUMOR; LYMPHOCYTE; METABOLISM; ODDS RATIO; RISK FACTOR; TELOMERE; TELOMERE SHORTENING;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

EID: 84929501533     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.03.011     Document Type: Article

References (50)

1. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673.
2. de L.T., Shelterin the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
3. Greider C.W., Telomere length regulation Annu Rev Biochem 1996, 65:337-365.
4. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
5. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973, 41:181-190.
6. Watson J.D. Origin of concatemeric T7 DNA. Nat New Biol 1972, 239:197-201.
7. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
8. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 2002, 297:565-569.
9. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
10. de Lange T. Telomeres and senescence: ending the debate. Science 1998, 279:334-335.
11. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
12. Bryan T.M., Englezou A., Gupta J., Bacchetti S., Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14:4240-4248.
13. Bryan T.M., Englezou A., la-Pozza L., Dunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997, 3:1271-1274.
14. Wu X., Amos C.I., Zhu Y., Zhao H., Grossman B.H., Shay J.W., et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003, 95:1211-1218.
15. Jang J.S., Choi Y.Y., Lee W.K., Choi J.E., Cha S.I., Kim Y.J., et al. Telomere length and the risk of lung cancer. Cancer Sci 2008, 99:1385-1389.
16. Seow W.J., Cawthon R.M., Purdue M.P., Hu W., Gao Y.T., Huang W.Y., et al. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res 2014, 74:4090-4098.
17. Shen M., Cawthon R., Rothman N., Weinstein S.J., Virtamo J., Hosgood H.D., et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 2011, 73:133-137.
18. Lan Q., Cawthon R., Gao Y., Hu W., Hosgood H.D., Barone-Adesi F., et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE 2013, 8:e59230.
19. Der-Sarkissian H., Bacchetti S., Cazes L., Londono-Vallejo J.A. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene 2004, 23:1221-1228.
20. Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001, 107:67-77.
21. Soler D., Genesca A., Arnedo G., Egozcue J., Tusell L. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells. Genes Chromosomes Cancer 2005, 44:339-350.
22. Zheng Y.L., Zhang F., Sun B., Du J., Sun C., Yuan J., et al. Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell Cycle 2014, 13:1765-1776.
23. Heaphy C.M., Subhawong A.P., Hong S.M., Goggins M.G., Montgomery E.A., Gabrielson E., et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 2011, 179:1608-1615.
24. Sakellariou D., Chiourea M., Raftopoulou C., Gagos S. Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction. Neoplasia 2013, 15:1301-1313.
25. Henson J.D., Hannay J.A., McCarthy S.W., Royds J.A., Yeager T.R., Robinson R.A., et al. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 2005, 11:217-225.
26. Abedalthagafi M., Phillips J.J., Kim G.E., Mueller S., Haas-Kogen D.A., Marshall R.E., et al. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod Pathol 2013, 26:1425-1432.
27. Zheng Y.L., Loffredo C.A., Yu Z., Jones R.T., Krasna M.J., Alberg A.J., et al. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis 2003, 24:269-274.
28. Zheng Y.L., Loffredo C.A., Alberg A.J., Yu Z., Jones R.T., Perlmutter D., et al. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res 2005, 65:9566-9573.
29. Zheng Y.L., Zhou X., Loffredo C.A., Shields P.G., Sun B. Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk. Hum Mol Genet 2011, 20:378-386.
30. Martinez P., Thanasoula M., Munoz P., Liao C., Tejera A., McNees C., et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 2009, 23:2060-2075.
31. Episkopou H., Draskovic I., Van B.A., Tilman G., Mattiussi M., Gobin M., et al. Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res 2014, 42:4391-4405.
32. Cesare A.J., Griffith J.D. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 2004, 24:9948-9957.
33. Hosgood H.D., Cawthon R., He X., Chanock S., Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009, 66:157-161.
34. Calado R.T., Young N.S. Telomere diseases. N Engl J Med 2009, 361:2353-2365.
35. Callen E., Surralles J. Telomere dysfunction in genome instability syndromes. Mutat Res 2004, 567:85-104.
36. Ho H.Y., Cheng M.L., Lu F.J., Chou Y.H., Stern A., Liang C.M., et al. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic Biol Med 2000, 29:156-169.
37. Kurz D.J., Decary S., Hong Y., Trivier E., Akhmedov A., Erusalimsky J.D. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 2004, 117:2417-2426.
38. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344.
39. Saretzki G., Von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann NY Acad Sci 2002, 959:24-29.
40. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91:9857-9860.
41. Nelson N.D., Bertuch A.A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res 2012, 730:43-51.
42. Hartwig F.P., Collares T. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment. Ageing Res Rev 2013, 12:642-652.
43. Gramatges M.M., Bertuch A.A. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res 2013, 162:353-363.
44. Martinez P., Blasco M.A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 2011, 11:161-176.
45. Choi J., Southworth L.K., Sarin K.Y., Venteicher A.S., Ma W., Chang W., et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 2008, 4:e10.
46. Park J.I., Venteicher A.S., Hong J.Y., Choi J., Jun S., Shkreli M., et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009, 460:66-72.
47. Goukassian D., Gad F., Yaar M., Eller M.S., Nehal U.S., Gilchrest B.A. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J 2000, 14:1325-1334.
48. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729.
49. Karanjawala Z.E., Lieber M.R. DNA damage and aging. Mech Ageing Dev 2004, 125:405-416.
50. Artandi S.E., Alson S., Tietze M.K., Sharpless N.E., Ye S., Greenberg R.A., et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 2002, 99:8191-8196.